We are live on
!
Find out more
BAMF
BI Asset Management Fondsmaeglerselskab Portfolio holdings
AUM
$12.6B
1-Year Est. Return
41.69%
This Fund
S&P 500
This Quarter
Est. Return
+0.3%
1 Year Est. Return
+41.69%
3 Year Est. Return
+134.93%
5 Year Est. Return
+172.69%
10 Year Est. Return
+588.15%
AUM
$2.64B
AUM Growth
+$34.5M
(+1.3%)
Cap. Flow
+$52M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
24.84%
Holding
412
New
29
Increased
125
Reduced
114
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$16.3M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$15.9M |
| 3 |
PepsiCo
PEP
|
+$15.1M |
| 4 |
Nucor
NUE
|
+$14.2M |
| 5 |
Coca-Cola
KO
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$20.5M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$19.3M |
| 3 |
Kimberly-Clark
KMB
|
+$18.6M |
| 4 |
Morgan Stanley
MS
|
+$13.4M |
| 5 |
Automatic Data Processing
ADP
|
+$11.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.02% |
| 2 | Financials | 15.82% |
| 3 | Healthcare | 15.53% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Communication Services | 9.46% |
Similar funds
ECM
LPC
IMPI
ZIG
EIG
ZIM
AIM
BI Asset Management Fondsmaeglerselskab's Q3 2021 Portfolio in Review
As of Q3 2021, BI Asset Management Fondsmaeglerselskab held 412 positions worth $2.64B, up 1.3% from $2.61B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
BI Asset Management Fondsmaeglerselskab's Q3 2021 filing shows 29 new, 125 increased, 114 reduced and 45 closed positions. Its largest new stake was Carlyle Group: 116,207 shares worth $5.49M. The largest sale was Marsh, an estimated $20.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- BI Asset Management Fondsmaeglerselskab's largest Q3 2021 buy was Carlyle Group: 116,207 shares worth $5.49M.
- BI Asset Management Fondsmaeglerselskab added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $16.3M increase.
- BI Asset Management Fondsmaeglerselskab's biggest Q3 2021 reduction was Marsh, cutting an estimated $20.5M.
- BI Asset Management Fondsmaeglerselskab fully exited Thermo Fisher Scientific in Q3 2021, selling an estimated $19.3M.
- BI Asset Management Fondsmaeglerselskab's ten largest holdings make up 25% of its $2.64B portfolio in Q3 2021.
- BI Asset Management Fondsmaeglerselskab opened 29 new positions and closed 45 in Q3 2021.
- BI Asset Management Fondsmaeglerselskab's portfolio value rose 1.3% quarter-over-quarter to $2.64B.
Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q3 2021, filed 9 Nov 2021.